Inhibitory effects of curculigoside on human liver cytochrome P450 enzymes

References

• Basheer L, Kerem Z. (2015). Interactions between CYP3A4 and dietary polyphenols. Oxid Med Cell Longev 2015:854015.
   PubMed Web of Science ®Google Scholar
• Dall'Acqua S, Shrestha BB, Comai S, et al. (2009). Two phenolic glycosides from Curculigo orchioides Gaertn. Fitoterapia 80:279–82.
   PubMed Web of Science ®Google Scholar
• Ding H, Gao G, Zhang L, et al. (2016). The protective effects of curculigoside A on adjuvant-induced arthritis by inhibiting NF-кB/NLRP3 activation in rats. Int Immunopharmacol 30:43–9.
   PubMed Web of Science ®Google Scholar
• Fasinu PS, Gutmann H, Schiller H, et al. (2013). The potential of Hypoxis hemerocallidea for herb-drug interaction. Pharm Biol 51:1499–507.
   PubMed Web of Science ®Google Scholar
• Grimm SW, Einolf HJ, Hall SD, et al. (2009). The conduct of in vitro studies to address time-dependent inhibition of drug-metabolizing enzymes: a perspective of the pharmaceutical research and manufacturers of America. Drug Metab Dispos 37:1355–70.
   PubMed Web of Science ®Google Scholar
• Gu J, Weng Y, Zhang QY, et al. (2003). Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase. J Biol Chem 278:25895–901.
   PubMed Web of Science ®Google Scholar
• Jeong HU, Kong TY, Kwon SS, et al. (2013). Effect of honokiol on cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes. Molecules 18:10681–93.
   PubMed Web of Science ®Google Scholar
• Lee SY, Jang H, Lee JY, et al. (2014). Inhibition of cytochrome P450 by ethambutol in human liver microsomes. Toxicol Lett 229:33–40.
   PubMed Web of Science ®Google Scholar
• Lee SY, Lee JY, Kang W, et al. (2013). Cytochrome P450-mediated herb-drug interaction potential of Galgeun-tang. Food Chem Toxicol 51:343–9.
   PubMed Web of Science ®Google Scholar
• Leite PM, Martins MA, Castilho RO. (2016). Review on mechanisms and interactions in concomitant use of herbs and warfarin therapy. Biomed Pharmacother 83:14–21.
   PubMed Web of Science ®Google Scholar
• Li AP. (2001). Screening for human ADME/Tox drug properties in drug discovery. Drug Disc Today 6:357–66.
   PubMed Web of Science ®Google Scholar
• Li X, Wang K, Wei W, et al. (2013). In vitro metabolism of brucine by human liver microsomes and its interactions with CYP substrates. Chem Biol Interact 204:140–3.
   PubMed Web of Science ®Google Scholar
• Liu M, Li Y, Yang ST. (2014). Curculigoside improves osteogenesis of human amniotic fluid-derived stem cells. Stem Cells Dev 23:146–54.
   PubMed Web of Science ®Google Scholar
• Lv QL, Wang GH, Chen SH, et al. (2016). In vitro and in vivo inhibitory effects of glycyrrhetinic acid in mice and human cytochrome P450 3A4. Int J Environ Res Public Health 13:84.
   Web of Science ®Google Scholar
• Meng Q, Liu K. (2014). Pharmacokinetic interactions between herbal medicines and prescribed drugs: focus on drug metabolic enzymes and transporters. Curr Drug Metab 15:791–807.
   PubMed Web of Science ®Google Scholar
• Monbaliu J, Gonzalez M, Bernard A, et al. (2016). In vitro and in vivo drug-drug interaction studies to assess the effect of abiraterone acetate, abiraterone, and metabolites of abiraterone on CYP2C8 activity. Drug Metab Dispos. 44:1682–91.
   Google Scholar
• Murali VP, Kuttan G. (2016). Curculigo orchioides Gaertn effectively ameliorates the uro- and nephrotoxicities induced by cyclophosphamide administration in experimental animals. Integr Cancer Ther 15:205–15.
   PubMed Web of Science ®Google Scholar
• Nie Y, Dong X, He Y, et al. (2013). Medicinal plants of genus Curculigo: traditional uses and a phytochemical and ethnopharmacological review. J Ethnopharmacol 147:547–63.
   PubMed Web of Science ®Google Scholar
• Niwa T, Yamazaki H. (2012). Comparison of cytochrome P450 2C subfamily members in terms of drug oxidation rates and substrate inhibition. Curr Drug Metab 13:1145–59.
   PubMed Web of Science ®Google Scholar
• Peng Y, Wu H, Zhang X, et al. (2015). A comprehensive assay for nine major cytochrome P450 enzymes activities with 16 probe reactions on human liver microsomes by a single LC/MS/MS run to support reliable in vitro inhibitory drug-drug interaction evaluation. Xenobiotica 45:961–77.
   PubMed Web of Science ®Google Scholar
• Qi XY, Liang SC, Ge GB, et al. (2013). Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes. Food Chem Toxicol 56:392–7.
   PubMed Web of Science ®Google Scholar
• Ramchandani D, Ganeshpurkar A, Bansal D, et al. (2014). Protective effect of curculigo orchioides extract on cyclophosphamide-induced neurotoxicity in murine model. Toxicol Int 21:232–5.
   PubMedGoogle Scholar
• Seervi M, Lotankar S, Barbar S, Sathaye S. (2016). Assessment of cytochrome P450 inhibition and induction potential of lupeol and betulin in rat liver microsomes. Drug Metab Pers Ther 31:115–22.
   PubMedGoogle Scholar
• Srinivas NR. (2016). Clinical drug-drug interactions of bosentan, a potent endothelial receptor antagonist, with various drugs: physiological role of enzymes and transporters. Gen Physiol Biophys 35:243–58.
   PubMed Web of Science ®Google Scholar
• Sun H, Scott DO. (2011). Impact of genetic polymorphisms of cytochrome P450 2 C (CYP2C) enzymes on the drug metabolism and design of antidiabetics. Chem Biol Interact 194:159–67.
   PubMed Web of Science ®Google Scholar
• Sun M, Tang Y, Ding T, et al. (2014). Inhibitory effects of celastrol on rat liver cytochrome P450 1A2, 2C11, 2D6, 2E1 and 3A2 activity. Fitoterapia 92:1–8.
   PubMed Web of Science ®Google Scholar
• Tacchini M, Spagnoletti A, Marieschi M, et al. (2015). Phytochemical profile and bioactivity of traditional ayurvedic decoctions and hydro-alcoholic macerations of Boerhaavia diffusa L. and Curculigo orchioides Gaertn. Nat Prod Res 29:2071–9.
   PubMed Web of Science ®Google Scholar
• Wrighton SA, Stevens JC. (1992). The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol 22:1–21.
   PubMed Web of Science ®Google Scholar
• Wu XY, Li JZ, Guo JZ, Hou BY. (2012). Ameliorative effects of curculigoside from Curculigo orchioides Gaertn on learning and memory in aged rats. Molecules 17:10108–18.
   PubMed Web of Science ®Google Scholar
• Yan Z, Caldwell GW. (2001). Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery. Curr Top Med Chem 1:403–25.
   PubMedGoogle Scholar
• Yang XX, Hu ZP, Duan W, et al. (2006). Drug-herb interactions: eliminating toxicity with hard drug design. Curr Pharm Des 12:4649–64.
   PubMed Web of Science ®Google Scholar
• Yang JM, Ip SP, Xian Y, et al. (2012). Impact of the herbal medicine Sophora flavescens on the oral pharmacokinetics of indinavir in rats: the involvement of CYP3A and P-glycoprotein. PLoS One 7:e31312.
   PubMed Web of Science ®Google Scholar
• Yuan TT, Xu HT, Zhao L, et al. (2015). Pharmacokinetic and tissue distribution profile of curculigoside after oral and intravenously injection administration in rats by liquid chromatography-mass spectrometry. Fitoterapia 101:64–72.
   PubMed Web of Science ®Google Scholar
• Zanger UM, Schwab M. (2013). Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 138:103–41.
   PubMed Web of Science ®Google Scholar
• Zhang FL, He X, Zhai YR, et al. (2015). Mechanism-based inhibition of CYPs and RMs-induced hepatoxicity by rutaecarpine. Xenobiotica 45:978–89.
   PubMed Web of Science ®Google Scholar
• Zhang JW, Liu Y, Cheng J, et al. (2007). Inhibition of human liver cytochrome P450 by star fruit juice. J Pharm Pharm Sci 10:496–503.
   PubMed Web of Science ®Google Scholar
• Zhang H, Ya G, Rui H. (2017). Inhibitory effects of triptolide on human liver cytochrome p450 enzymes and P-glycoprotein. Eur J Drug Metab Pharmacokinet 42:89–98.
   PubMed Web of Science ®Google Scholar
• Zhao G, Yuan F, Zhu J. (2014). An LC-MS/MS method for determination of curculigoside with anti-osteoporotic activity in rat plasma and application to a pharmacokinetic study. Biomed Chromatogr 28:341–7.
   PubMed Web of Science ®Google Scholar
• Zia H, Murray GI, Vyhlidal CA, et al. (2015). CYP3A isoforms in Ewing's sarcoma tumours: an immunohistochemical study with clinical correlation. Int J Exp Pathol 96:81–6.
   PubMed Web of Science ®Google Scholar